A detailed history of Kbc Group Nv transactions in Insmed Inc stock. As of the latest transaction made, Kbc Group Nv holds 4,310 shares of INSM stock, worth $284,934. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,310
Previous 3,580 20.39%
Holding current value
$284,934
Previous $240,000 31.25%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$62.0 - $79.01 $45,260 - $57,677
730 Added 20.39%
4,310 $315,000
Q2 2024

Jul 17, 2024

BUY
$22.0 - $69.71 $8,910 - $28,232
405 Added 12.76%
3,580 $240,000
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $74,358 - $100,774
3,175 New
3,175 $98,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.96B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.